Biofrontera Inc (NAS:BFRI)

$ 1.07 -0.02 (-1.83%) Market Cap: 5.45 Mil Enterprise Value: 9.53 Mil PE Ratio: 0 PB Ratio: 0.35 GF Score: 18/100

Q1 2024 Biofrontera Inc Earnings Call Transcript
1 day ago

$1.09 (-9.92%)

Earnings
Q4 2023 Biofrontera Inc Earnings Call Transcript
Mar 18, 2024

$1.26 (-18.71%)

Earnings
Q3 2023 Biofrontera Inc Earnings Call Transcript
Nov 10, 2023

$3.81 (-2.56%)

Earnings
Q4 2022 Biofrontera Inc Earnings Call Transcript
Mar 08, 2023

$12.5 (-3.01%)

Earnings
Biofrontera Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 21, 2023
Biofrontera Inc Annual Shareholders Meeting Transcript
Dec 12, 2022
Q3 2022 Biofrontera Inc Earnings Call Transcript
Nov 14, 2022

$20

Earnings
Biofrontera Inc at LD Micro Main Event Transcript
Oct 26, 2022
Q4 2021 Biofrontera Inc Earnings Call Transcript
Apr 08, 2022

$92.4 (+14.36%)

Earnings

Q3 2023 Biofrontera Inc Earnings Call Transcript

Nov 10, 2023 / 03:00PM GMT

Release Date Price: $3.81 (-2.56%)

Transcript 10-Q8-K

Operator

Good day, and welcome to the Biofrontera Inc., third-quarter 2023 financial results and business update conference call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Tirth Patel with LHA Investor Relations. Please go ahead.

Tirth Patel

LHA Investor Relations - IR

Good morning, and welcome to Biofrontera Inc.'s third-quarter 2023 financial results and business update conference call. Please note that certain information discussed during today's call by management is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act.

We caution listeners that Biofrontera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.